摘要
目的 探讨羟基喜树碱(HCPT)、小剂量结核菌素(BCG)交替膀胱灌注预防膀胱癌术后复发的效果.方法 选择312例膀胱癌术后患者,随机分为HCPT和小剂量BCG交替膀胱灌注组(A组)、HCPT膀胱灌注组(B组)各156例.A组:术后第7d用HCPT 10mg+生理盐水20 mL膀胱灌注,第14d用BCG 10mg+生理盐水40mL膀胱灌注;之后每隔3d交替灌注1次,至术后第56d;术后第63d开始,每隔1周交替灌注1次,各灌注8次;术后第183d开始,每隔15d交替灌注1次,各灌注8次;术后第438d开始,每隔1个月交替灌注1次至术后2年.B组:自术后第7d起,用HCPT 10mg+生理盐水20mL膀胱灌注,每周灌注1次,至术后第56d;术后第70d开始,每隔2周灌注1次,共8次;术后第198d开始,每隔1个月灌注1次,共8次;术后第468d开始,每隔2个月灌注1次至术后2年.各种药物灌注剂量同首次灌注.分别观察两组0~18、19 ~24、25 ~60个月的肿瘤复发率及毒副反应.结果 随访60个月,A组复发率分别为0(0~18个月)、3.21%(19 ~24个月)、18.67%(25~60个月),B组分别为11.54%、7.10%、20.13%,两组0~18个月的复发率比较差异有统计学意义(P<0.05);两组均出现非细菌性膀胱炎、血尿、低热、血象异常等毒副反应,但两组比较差异均无统计学意义(P>0.05).结论 HCPT和小剂量BCG交替膀胱灌注预防膀胱癌术后复发效果较好,毒副反应较轻且发生率低.
Objectives To investigate the effect of low dose tuberculin (BCG) and hydroxycamptothecin (HCPT) alternately intravesical instillation after the post-operative recurrence of bladder cancer.Methods 312 cases of bladder cancer after operation were randomly divided into the group of alternating intravesical instillation of HCPT and low-dose BCG (A group) and HCPT group(B group),156 cases in each group.Group A:HCPT 10mg added to normal saline 20ml were vesically irrigated 7 days after operation,BCG 10mg added to normal saline 40ml were vesically irrigated 14 days after operation; then alternately vesical irrigation was given every other 3 day till 56 days after operation; after 63 days of operation,alternately vesical irrigated every 1 week,8 times for each drug; after 183 days of operation,altemately vesical irrigated every 15 days,8 times for each drug; after 438 days of operation,alternately vesical irrigated till 2 years post-operation.Group B:This group was infused with HCPT 10mg added to normal saline 20ml after 7 days of operation,then was given once a week to 56 days of postoperation; then once every other 2 weeks to 197 days of post-operation; once every other 1 month for 8 times; once every other 2 months till 2 years of post-operation.The total dose for each time of irrigation is the same with the first time.The Recurrence rate and side effects were observed 0 ~ 18 months,19 ~ 24months and 25 ~ 60months separately.Results After 60 months of follow-up,the recurrence rate was 0 (0 ~ 18months),3.21% (19 ~ 24 months) ; 18.67% (25 ~ 60months) for group A,and 11.54%,7.10% and 20.13% for group B separately.The difference between the recurrence rate of the two groups from 0-18 months was significant in statistics (P 〈 0.05).Nonbacterial cystitis,hema turia,fever and abnormal routine blood test results were observed in both groups,but the difference was not significant in statistics(P 〉 0.05).Conclusions Low dose tuberculin (BCG) and hydroxycamptothecin alternately intravesical therapy has a good effect on post-operation recurrence prevention with fewer and slighter side effects.
出处
《国际泌尿系统杂志》
2014年第2期190-193,共4页
International Journal of Urology and Nephrology
基金
基金项目:沧州市科学技术研究与发展指导计划项目0ZD73)
关键词
膀胱肿瘤
结核菌素
喜树碱
Urinary Bladder Neoplasms
Tuberculin
Camptothecin